FDA Inspection 971105 — Matrixx Initiatives, Inc.
The FDA completed an inspection of Matrixx Initiatives, Inc. on May 11, 2016 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scottsdale, AZ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)